MSTX hosted a conference on sickle cell disease on Sept 19th. They're presenting at a rare disease roundtable today and they are presenting at the 12th annual bio investor forum on Oct 8th. Could be why they're up today. And CPRX already is a winner.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.